Skip Navigation
Back

Episode 27

The Use of Stem Cells in Oral and Maxillofacial Surgery

What role do stem cells actually play in oral and maxillofacial surgery?

In this episode of Oral Surgery Insights, Dr. Brandon Rehrer and Dr. Russ Lieblick separate the promise of regenerative medicine from the hype. They explain what stem cells are and how they already drive the healing behind bone grafts and dental implants. They also cover how biologics like platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) help guide them. Then they look ahead at tissue engineering, TMJ cartilage repair and nerve regeneration, and talk about why safety, ethics and peer-reviewed evidence must come first.

If you've seen ads for stem cell cures, or wondered whether banking cells from wisdom teeth is worth it, this episode gives you a balanced, practical look at where the science stands today.

In this episode, you'll learn:

  • What makes a stem cell unique, and why that matters for bone regeneration
  • How the mouth itself is a source of mesenchymal stem cells
  • How PRP and PRF support healing in bone grafting and sinus augmentation
  • Where tissue engineering, TMJ repair and nerve regeneration research is headed
  • What to know about stem cell banking and stem cell marketing claims

Whether you're a patient curious about regenerative medicine or a clinician keeping up with the field, this episode will help you understand what's available now and what's still in the research phase.

You know, Russ, when most people hear the term stem cells, they tend to think of something futuristic, almost science fiction: lab-grown organs, revolutionary cures, dramatic breakthroughs.

That's true, Brandon. It's a term that captures attention. But what's important to understand is that regenerative medicine isn't just theoretical anymore. In measured, evidence-based ways, stem cell science is already influencing oral and maxillofacial surgery.

That's a great introduction to today's discussion. Welcome to Oral Surgery Insights. I'm Dr. Brandon Rehrer, here with Dr. Russ Lieblick. Today, we're exploring the role of stem cells in oral and maxillofacial surgery: what they are, how they relate to what we already do, and where the science may be headed.

And as always, our goal is clarity. Stem cells are powerful biological tools, but they require thoughtful research, careful regulation, and responsible clinical application.

So let's begin with the fundamentals. A stem cell has two defining characteristics. It can self-renew, meaning it can replicate itself, and it can differentiate into other specialized cell types. In our field, those specialized cells include bone-forming cells, cartilage cells, and other connective tissue components.

That's where this becomes highly relevant to oral and maxillofacial surgery, because so much of what we do involves bone regeneration and reconstruction. When we place a dental implant or perform a bone graft, we're relying on the body's innate ability to heal and regenerate. Stem cells are central players in that process. They migrate to the surgical site, respond to signaling molecules, and differentiate into the cells needed to rebuild bone.

Exactly. Regeneration has always been part of oral surgery. What's changed is our understanding of the biology behind it, and how we can potentially enhance that process.

Interestingly, the oral cavity itself is a source of mesenchymal stem cells. They've been identified in dental pulp, the periodontal ligament, and even in primary teeth. That discovery has led to significant research into dental-derived stem cells.

In laboratory settings, these cells have demonstrated the capacity to form bone and connective tissues. That has clear implications for craniofacial reconstruction after trauma, pathology, or congenital defects.

Now, it's important to be realistic. We are not routinely regenerating entire segments of jawbone with stem cell therapies in everyday practice. Much of that work remains in research and early clinical investigation.

Where stem cell science most directly intersects with current practice is through biologics, materials that support and enhance the body's healing response. Platelet-rich plasma and platelet-rich fibrin are good examples. These concentrates contain growth factors that act as signaling molecules. They don't create stem cells, but they help guide them, encouraging migration, proliferation, and tissue formation. In procedures like bone grafting or sinus augmentation, they may contribute to a more favorable healing environment.

Beyond that, there's growing interest in tissue engineering. The basic model involves three elements: a scaffold to provide structure, signaling molecules to direct healing, and cells, potentially stem cells, to generate new tissue.

Traditionally, when significant bone reconstruction is needed, we often harvested bone from another area of the patient's body. Those procedures are highly successful, but they do involve additional surgery. The promise of tissue engineering is that one day, we may be able to reduce that need by promoting targeted regeneration.

Another area of investigation is the temporomandibular joint. The TMJ contains both bone and cartilage, and cartilage has limited natural healing capacity. Researchers are exploring whether stem cell-based strategies could eventually help repair or regenerate damaged joint structures.

There's also interest in nerve regeneration. In cases of traumatic injury or complex jaw surgery, sensory nerves can be affected. While still investigational, biologically driven approaches may one day enhance nerve repair.

With all of this potential, it's critical to discuss safety and ethics. In oral and maxillofacial applications, we're generally referring to adult mesenchymal stem cells, not embryonic stem cells. Even so, their use must follow strict regulatory standards.

That's particularly important because patients may encounter advertisements promoting stem cell cures for a wide range of conditions. As clinicians, we rely on peer-reviewed evidence and established guidelines. Scientific validation must always precede widespread adoption.

There's also growing public interest in stem cell banking, preserving cells from extracted wisdom teeth or primary teeth. The concept is scientifically intriguing, but many future applications remain theoretical. Patients considering those services should understand both the possibilities and the uncertainties. It's an evolving area of research, not a guaranteed therapeutic solution.

What's most compelling to me is the broader shift in philosophy. Surgery is moving from purely mechanical reconstruction toward biologically guided regeneration, working with the body's intrinsic healing capacity.

And oral and maxillofacial surgery is uniquely positioned in that evolution. We operate at the intersection of bone biology, dental science, and surgical reconstruction.

For patients listening, the takeaway is this: Regenerative medicine is advancing steadily. Some aspects already support healing in subtle but meaningful ways. Others are still in the research phase.

And for clinicians, it's a reminder to remain informed and measured. The future will likely include expanded regenerative techniques, but they must be grounded in evidence and integrated responsibly.

The human body has remarkable restorative potential. Our responsibility is to understand that biology deeply and apply it thoughtfully. We hope today's discussion has provided a balanced and practical look at stem cells in oral and maxillofacial surgery, separating promise from speculation.

Thank you for joining us on Oral Surgery Insights. We appreciate you spending your time with us today, and we wish you all the very best.